Quadrature Capital LTD Perkinelmer Inc Transaction History

Quadrature Capital LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	N/A	3,309 Added 27.41%	15,380 $1.61 Billion
Q1 2024 May 14, 2024	BUY	N/A	12,071 New	12,071 $1.27 Billion
Q3 2023 Nov 14, 2023	BUY	$115.88 - $122.81 $2.27 Million - $2.41 Million	19,595 Added 328.39%	25,562 $3.09 Million
Q2 2023 Aug 14, 2023	BUY	$0.0 - $137.11 $0 - $818,135	5,967 New	5,967 $0
Q2 2021 Aug 16, 2021	SELL	$127.81 - $155.84 $204,496 - $249,344	-1,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$120.35 - $160.53 $192,560 - $256,848	1,600 New	1,600 $205,000
Q4 2020 Feb 16, 2021	SELL	$122.05 - $147.91 $4.36 Million - $5.29 Million	-35,747 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$97.09 - $125.51 $1.98 Million - $2.55 Million	20,349 Added 132.15%	35,747 $4.49 Million
Q2 2020 Aug 14, 2020	SELL	$70.83 - $105.31 $2.41 Million - $3.58 Million	-33,982 Reduced 68.82%	15,398 $1.51 Million
Q2 2019 Aug 14, 2019	BUY	$84.06 - $101.12 $4.15 Million - $4.99 Million	49,380 New	49,380 $0

571

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.